Table 2.
WM | WL | WL-HP | ||||
---|---|---|---|---|---|---|
Before | After | Before | After | Before | After | |
Plasma hormone and metabolite concentrations | ||||||
Glucose (mg/dL) | ||||||
Basal | 96.2 ± 4.1 | 94.7 ± 4.3 | 96.1 ± 3.1 | 92.9 ± 1.8 | 92.2 ± 1.3 | 91.9 ± 1.9 |
HECP | 102.3 ± 1.3* | 102.4 ± 0.9* | 101.2 ± 1.0* | 102.5 ± 1.0* | 100.5 ± 0.9* | 101.6 ± 1.4* |
Insulin (μU/mL) | ||||||
Basal | 8.2 ± 1.5 | 7.0 ± 1.5 | 5.9 ± 1.1 | 3.5 ± 0.5† | 7.7 ± 1.3 | 5.0 ± 0.8† |
HECP | 56.6 ± 6.7* | 57.0 ± 2.2* | 53.3 ± 5.3* | 55.2 ± 5.2* | 66.3 ± 5.1* | 63.1 ± 5.4* |
Free fatty acids (mM) | ||||||
Basal | 0.71 ± 0.06 | 0.70 ± 0.04 | 0.64 ± 0.04 | 0.54 ± 0.04† | 0.71 ± 0.06 | 0.61 ± 0.02† |
HECP | 0.10 ± 0.02* | 0.07 ± 0.01* | 0.06 ± 0.01* | 0.04 ± 0.01* | 0.05 ± 0.01* | 0.03 ± 0.01* |
Branched-chain amino acids (μM) | ||||||
Basal | 377 ± 19 | 385 ± 18 | 375 ± 8 | 339 ± 15† | 386 ± 13 | 361 ± 8† |
HECP | 237 ± 29* | 235 ± 25* | 209 ± 14* | 159 ± 12*† | 216 ± 13* | 183 ± 12*† |
Essential amino acids (μM) | ||||||
Basal | 907 ± 75 | 942 ± 75 | 845 ± 25 | 818 ± 44 | 830 ± 31 | 856 ± 41 |
HECP | 661 ± 87* | 664 ± 77* | 558 ± 45* | 468 ± 52*† | 580 ± 41* | 533 ± 32*† |
Non-essential amino acids (μM) | ||||||
Basal | 1,006 ± 90 | 998 ± 98 | 921 ± 48 | 881 ± 53 | 954 ± 36 | 882 ± 53 |
HECP | 846 ± 91* | 799 ± 85* | 709 ± 49* | 616 ± 55* | 770 ± 43* | 684 ± 39* |
Total amino acids (μM) | ||||||
Basal | 1,913 ± 164 | 1,940 ± 172 | 1,766 ± 69 | 1,699 ± 92 | 1,784 ± 61 | 1,738 ± 87 |
HECP | 1,507 ± 174* | 1,463 ± 158* | 1,268 ± 86* | 1,083 ± 104* | 1,349 ± 80* | 1,217 ± 64* |
Sum of C3 and C5 acylcarnitines (μM) | 0.37 ± 0.05 | 0.37 ± 0.05 | 0.39 ± 0.03 | 0.32 ± 0.02 | 0.36 ± 0.03 | 0.32 ± 0.02 |
Fibroblast growth factor 21 (pg/mL) | 219 ± 46 | 247 ± 52 | 177 ± 36 | 148 ± 24† | 168 ± 25 | 116 ± 13† |
Glucose kinetics | ||||||
Basal glucose Ra | ||||||
(μmol/min) | 761 ± 15 | 780 ± 30 | 789 ± 36 | 736 ± 25† | 784 ± 31 | 713 ± 26† |
(μmol/kg FFM/min) | 15.7 ± 0.6 | 16.0 ± 0.6 | 16.3 ± 0.7 | 15.8 ± 0.6 | 17.2 ± 0.7 | 16.0 ± 0.6 |
GIR during the HECP | ||||||
(μmol/min) | 2,619 ± 554 | 2,601 ± 429 | 2,512 ± 197 | 2,986 ± 164†# | 2,893 ± 337 | 2,798 ± 289 |
(μmol/kg FFM/min) | 55.7 ± 13.2 | 55.0 ± 10.6 | 52.6 ± 4.9 | 64.6 ± 4.5†# | 63.2 ± 6.9 | 62.8 ± 6.3 |
Glucose Rd during the HECP | ||||||
(μmol/min) | 2,741 ± 537 | 2,681 ± 383 | 2,649 ± 214 | 3,108 ± 184†# | 2,976 ± 317 | 2,905 ± 270 |
(μmol/kg FFM/min) | 58.2 ± 12.9 | 56.5 ± 9.6 | 55.5 ± 5.3 | 67.3 ± 5.0†# | 65.0 ± 6.5 | 65.2 ± 5.9 |
Data are expressed as mean ± SEM.
FFM: fat-free mass. GIR: glucose infusion rate. HECP: hyperinsulinemic-euglycemic clamp procedure. Ra: rate of appearance. Rd: rate of disappearance. WL: weight loss (n = 10). WL-HP: weight loss high-protein (n = 10). WM: weight maintenance (n = 7).
Value significantly different from corresponding basal value (P < 0.05).
Value significantly different from corresponding value in the WM group (P < 0.05).
Value significantly different from corresponding value in the WL-HP group (P < 0.01).
See also Figure S1.